How Wegovy's Part D Approval Will Affect Medicare Plans

How Wegovy’s Part D Approval Will Affect Medicare Plans: Weight loss drugs like Wegovy and Ozempic have generated a lot of buzz in the media recently. Ozempic® (semaglutide) has already been approved by Medicare part D Plans. While typically prescribed to treat issues like Type 2 Diabetes, in Ozempic’s case, and cardiovascular issues, in Wegovy’s case, they’re both recognized as highly effective in aiding weight loss. Medicare expert and author of “Maximize Your Medicare” Jae Oh acknowledges that as Wegovy undergoes the approval process for coverage under Medicare Part D, it is unsure when individual plans will begin to offer financial aid. Until then, the cost to purchase this drug will have to be paid out-of-pocket. For more information regarding this topic, watch the video to learn How Wegovys Part D Approval Will Affect Plans!